New device could stop deadly Post-Birth bleeding

NCT ID NCT06646653

Recruiting now Disease control Sponsor: ResQ Medical Ltd Source: ClinicalTrials.gov ↗

First seen Apr 07, 2026 · Last updated May 25, 2026 · Updated 9 times

Summary

This study tests a device called the Alma system for women who have severe bleeding after childbirth (postpartum hemorrhage) that does not stop with standard treatments. About 50 women who experience this emergency will receive the Alma treatment. The goal is to see if the device safely controls bleeding and avoids the need for more invasive procedures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE (PRIMARY) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Maimonides Medical Center | Brooklyn, New York Hospital
NOT_YET_RECRUITING

Brooklyn, New York, 11219, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Shaare Zedek Medical Center
RECRUITING

Jerusalem, 9103102, Israel

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

POSTPARTUM HAEMORRHAGE (PPH) POSTPARTUM HEMORRHAGE (PRIMARY) PPH